Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CubeSmart (CUBE) vs Cassava Sciences Inc (FLNA) Price & Performance

CubeSmartTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

CubeSmart vs Cassava Sciences Inc — how do they compare? CubeSmart trades at $40.56 (market cap $9.19B), while Cassava Sciences Inc trades at $1.09 (market cap $56.04M). The key difference: CubeSmart is far larger — about 164× Cassava Sciences Inc's market cap, and CubeSmart pays a 5.22% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

CUBEFLNA
Market Cap
$9.19B$56.04M
Sector
Real EstateHealth
52-Week High
$42.34$4.64
52-Week Low
$35.36$1.09
Enterprise Value
$12.69B-$30.54M
Dividend Yield
5.22%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CubeSmart

No Aura AI signal available yet.

Cassava Sciences Inc

FLNA trades at $1.15, down 2.54% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company continues to report losses, with a net income of -$90.97M in 2025 and negative cash flow, though it has beaten EPS estimates for the last three quarters. Recent news highlights ongoing development in its TSC-related epilepsy therapies.

Despite consistent earnings beats, FLNA's negative profitability and cash burn pose significant risks. Analyst sentiment is positive with a 66.7% buy rating, but the stock's outlook depends heavily on clinical success and future funding. Investors should weigh the high-risk, high-reward nature of this biotech play.

Returns comparison

Trailing returns across standard periods

About CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Read more on CUBE

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA